Unintentional weight loss in people with Down syndrome may predict the onset of Alzheimer's disease long before typical cognitive symptoms like memory loss and dementia are apparent.
Jan 31, 2023
0
52
Researchers of the Faculty of Psychology, the Institute of Neurosciences (UBNeuro) and the Institute of Complex Systems (UBICS) of the University of Barcelona have identified, using functional magnetic resonance techniques, ...
Dec 13, 2022
0
46
Amyloid plaques—protein clumps that are one of the hallmarks of Alzheimer's disease—occur at roughly the same level in the brains of people with Down syndrome who have Alzheimer's as they do in people with forms of hereditary, ...
Dec 13, 2022
0
45
Researchers from Mass General for Children and colleagues have learned more about the effect of selective terminations on birth prevalence and population prevalence of people with Down syndrome in Australia and New Zealand.
Dec 9, 2022
0
8
A major challenge in testing new therapies for people with intellectual disability is finding accurate tools to measure whether the intervention or medication works. A new study by researchers at the UC Davis MIND Institute ...
Dec 5, 2022
0
6
Research on understanding the effect of extra chromosomes for conditions like Down syndrome typically involves examining what genes play a role in the symptoms of these conditions. However, researchers from Germany and the ...
Dec 1, 2022
0
53
The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer's disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. ...
Nov 18, 2022
0
115
Individuals with Down syndrome have less-frequent viral infections, but when present, these infections lead to more severe disease. New findings publishing on October 14 in the journal Immunity show that this is caused by ...
Oct 14, 2022
0
73
Children and young adults with Down syndrome are four times more likely to be diagnosed with diabetes, according to new research led by Queen Mary University of London and King's College London.
Oct 4, 2022
0
13
A new hormone treatment improved the cognitive function of six men with Down Syndrome by 10-30 percent, scientists said Thursday, adding the "promising" results may raise hopes of improving patients' quality of life.
Sep 4, 2022
1
23
